US Stock MarketDetailed Quotes

PSTV Plus Therapeutics

Watchlist
  • 1.6300
  • -0.0300-1.81%
Close Apr 23 16:00 ET
6.97MMarket Cap-384P/E (TTM)

About Plus Therapeutics Company

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Austin, TX.

Company Profile

SymbolPSTV
Company NamePlus Therapeutics
Listing DateDec 19, 2005
Founded1996
CEODr. Marc H. Hedrick,M.D.
MarketNASDAQ
Employees20
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4200 Marathon Boulevard,Suite 200
CityAustin
ProvinceTexas
CountryUnited States of America
Zip Code78756
Phone1-210-974-6900
Websitehttp://www.plustherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Marc H. Hedrick,M.D.
  • Director, Chief Executive Officer and President
  • 954.65K
  • Andrew Sims
  • Chief Financial Officer, Vice President, Finance and Principal Accounting Officer
  • 446.18K
  • Dr. Norman LaFrance,M.D.
  • Chief Medical Officer
  • 637.81K
  • Richard J. Hawkins
  • Chairman of the Board
  • 95.00K
  • Greg B. Petersen
  • Independent Director
  • 72.50K
  • Howard Clowes
  • Independent Director
  • 67.50K
  • Dr. An van Es-Johansson, M.D.
  • Independent Director
  • 57.50K
  • Dr. Robert P. Lenk, PhD
  • Independent Director
  • 45.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg